SCHEMBL753290

SCHEMBL753290

Cc1cccc(CS(=O)(=O)C(Br)Br)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
KMT2A Q03164 1/20 0.48
TAAR1 Q96RJ0 1/20 0.43
ACLY P53396 1/20 0.42
IDO1 P14902 2/20 0.42
CTBP2 P56545 1/20 0.41
POLB P06746 2/20 0.41
NR3C1 P04150 1/20 0.40
PGR P06401 1/20 0.40
NR3C2 P08235 1/20 0.40
TP53 P04637 4/20 0.40
LMNA P02545 2/20 0.40
TAS2R14 Q9NYV8 1/20 0.40
JAK2 O60674 1/20 0.39
S1PR4 O95977 1/20 0.39
F2 P00734 1/20 0.39
HPGD P15428 1/20 0.39
XBP1 P17861 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17571925 0.84 ALDH1A1 (0.49) ALDH1A1KMT2ATAAR1ACLYIDO1
SCHEMBL754046 0.80 EGFR (0.44) TAAR1IDO1
SCHEMBL4401170 0.79 ALDH1A1 (0.62) ALDH1A1KMT2ATAAR1IDO1POLB
SCHEMBL752569 0.79 PNMT (0.50) ALDH1A1KMT2ATAAR1IDO1CTBP2
SCHEMBL751782 0.77 KMT2A (0.49) ALDH1A1KMT2AIDO1POLBLMNA
SCHEMBL3894959 0.77 ALDH1A1 (0.53) ALDH1A1KMT2ATAAR1ACLYIDO1
SCHEMBL2377394 0.77 ALDH1A1 (0.49) ALDH1A1KMT2ATAAR1ACLYIDO1
SCHEMBL3626579 0.77 CA2 (0.52) ALDH1A1KMT2ALMNAF2HPGD
SCHEMBL754601 0.76 LMNA (0.37) ALDH1A1KMT2APOLBLMNAHPGD
SCHEMBL3590222 0.76 CA1 (0.57) ALDH1A1KMT2ATAAR1ACLYIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213166-B1 Biocidal compounds containing 2-methylisothiazolin-3-one and a haloalkylsulfone THOR GMBH (DE) 2012-03-21 EP claimed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US claimed
US-8287631-B2 Compounds for preventing ghost odour THOR GMBH (DE) 2012-10-16 US disclosed
EP-2430014-A1 ANTIVIRAL COMPOUNDS Gilead Sciences, Inc. (US) 2012-03-21 EP disclosed
US-20100186631-A1 Compounds for preventing ghost odour THOR GMBH (DE) 2010-07-29 US disclosed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone MBTD1, MPST, B2M ALDH1A1 553/4885KMT2A 2043/4885TAAR1 2058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.